Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIMARTHE study of maraviroc + ritonavir-boosted darunavir as early rescue therapy in HIV-1
2012-003501-10Phase 2Terminated
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of maraviroc, darunavir, ritonavir in Human immunodeficiency virus infection type 1, sponsored by Vall d'Hebron Research Institute. Started Jan 2013; status: terminated.
02
Drugs
maravirocdarunavirritonavir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2012-003501-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003501-10.